マルチプレックスアッセイの市場規模、シェア、動向分析レポート：製品別、タイプ別、技術タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

マルチプレックスアッセイ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のマルチプレックスアッセイ市場規模は2030年までに44億1,272万米ドルに達すると推定され、2025～2030年にかけて17.5%のCAGRで成長すると予測されています。

感染症の流行が拡大していることが、臨床検査におけるマルチプレックスアッセイの使用を後押ししています。例えば、2021年の米国がん協会によると、米国では190万人のがん患者が報告され、608万570人が死亡しています。マルチプレックスアッセイはがんの診断を助け、不必要な侵襲的生産を減らします。したがって、慢性疾患の増加は、これらのアッセイの必要性を高め、市場の成長を促進すると予想されます。近年、個別化医療の採用が増加していることも成長を促進する重要な要因です。

個別化医療とは、個々の患者の体質や疾病リスクに基づいて、治療法を改善するための正確な医療です。これらのアッセイは、個別化医療の包括的な診断に非常に有益です。例えば、2020年にMDPIジャーナルに掲載された紙製によると、マルチプレックスイムノアッセイは、関節リウマチ（RA）に関与する疾患と経路の全体像を提供し、同時にRAサブタイプのバイオマーカーシグネチャーを得ることができる複数のタンパク質を分析することで、患者が個別化医療の恩恵を受けることを可能にします。COVID-19パンデミックの間、マルチプレックス検査は、COVID-19の蔓延を効果的に管理する上で、ヘルスケア専門家にとって不可欠なツールであり続けた。さらに最近では、いくつかの非公開会社も新しいバージョンのマルチプレックスアッセイを開発しています。

例えば、2020年9月、LabCorpはインフルエンザA/B、COVID-19、呼吸器合胞体ウイルスのシングルパネル検査の診断のための家庭用コレクションバージョンを発売しました。さらに、シングルプレックスアッセイや従来型アッセイに対するマルチプレックスアッセイの利点は、今後数年間の産業の成長を後押しする可能性があります。これらの自動検査が提供するいくつかの利点には、マイクロサンプリング機能、1回の検査で測定できる多数のアレイ、迅速な結果、高い操作効率、簡単な操作、人件費の削減などがあります。このため、この産業は2021年に漸増的な成長を遂げており、予測期間中も同様の傾向が続くと予想されます。さらに、分子・タンパク質診断におけるバイオマーカーの検証の増加、高性能と自動化システムのニーズの高まりは、予測期間中に有利な機会を創出すると予想されます。

複数のバイオマーカー分析は、感染症、神経変性疾患、自己免疫疾患、がんのセグメントで幅広い応用が可能です。数多くのバイオマーカーが発見されており、新規診断薬が開発される可能性が高いです。例えば、CiplaはCOVID-19の迅速な結果をもたらすRT Direct multiplex PCRキットを発売しました。このような市場の開拓は、予測期間中にマルチプレックスアッセイの市場浸透率を高める可能性があります。マルチプレックスアッセイにおける技術の進歩と自動化は、正確な結果を出すための効率とスピードを向上させています。例えば、2020年7月、LuminexはxMAPにINTELLIFLEXシステムを提供し、1回の血清検査で複数の抗体を検出できる独自の機能など、新規アプリケーションを発見しました。

2022年5月には、Vela Diagnosticsが抗菌薬耐性遺伝子と尿路結石病原体を検出するための高度に自動化されたマルチプレックスPCRベースの検査を開始しました。したがって、新規の技術開発は近い将来、産業の成長を促進することができます。しかし、機器のコストが高いため、中低所得国の研究者や製造業者によるマルチプレックスアッセイの使用は制限される可能性があります。また、マルチプレックスアッセイの品質管理基準や規制はシングレックスアッセイに比べて厳しく、予測期間中の産業成長を阻害する可能性があります。

マルチプレックスアッセイ市場レポートハイライト

• 製品別では、消耗品セグメントが2024年に圧倒的なシェアを占めました。これは、診断検査数の増加とともに消耗品の購入が繰り返されるためです。
• バイオマーカー研究と臨床診断のためのプロテオミクス研究への注目の高まりにより、2024年にはタンパク質マルチプレックスアッセイタイプセグメントが産業を支配しました。
• フローサイトメトリー技術セグメントが2024年に大きなシェアを占めました。様々な企業による新規で技術的に先進的なフローサイトメータの発売への絶え間ない努力が、このセグメントを牽引する主要因です。
• 研究開発用途セグメントは、毒性、免疫療法の成功、薬剤反応バイオマーカーを評価するために臨床と前臨床段階でこれらのアッセイを利用するため、2024年に最大のシェアを占めました。
• 製薬・バイオテクノロジー企業エンドユーザー部門が2024年に産業をリードしたのは、多重化能力を高めるための製薬・バイオテクノロジー企業との提携や共同研究が増加したためです。
• 北米は、慢性疾患の蔓延による研究開発活動の活発化により、2024年に世界の産業を支配しました。
• アジア太平洋のは、新興国における病院数の増加、研究開発部門の発展、同地域におけるヘルスケアインフラへの高い需要により、2024～2030年にかけて最も速いCAGRを記録すると推定されます。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 世界マルチプレックスアッセイ市場の変数、動向、範囲

• マルチプレックスアッセイ市場の系統展望
  • 親市場の展望
• 浸透と成長の展望マッピング
• 市場促進要因分析
  • 慢性疾患と感染症の蔓延
  • シングルプレックスや従来型アッセイに比べてマルチプレックスの大きな利点
  • コンパニオン診断におけるマルチプレックスアッセイの適用拡大
  • 早期診断への意識の高まり
• 市場抑制要因分析
  • マルチプレックスアッセイの高額な投資コスト
  • 厳格な規制上の制約と基準
• 市場機会分析
  • 高スループットと自動化システムへのニーズの高まり
  • タンパク質と分子診断におけるバイオマーカーの検証の強化
• ポーターのファイブフォース分析
• SWOT分析（要因別）（政治・法律、経済、技術）

第4章 マルチプレックスアッセイ市場：セグメント分析、製品別、2018～2030年

• 世界のマルチプレックスアッセイ市場：製品変動分析
• 消耗品
  • 消耗品市場推定・予測、2018～2030年
• 機器
  • 機器市場推定・予測、2018～2030年
• ソフトウェア
  • ソフトウェア市場推定・予測、2018～2030年

第5章 マルチプレックスアッセイ市場：セグメント分析、タイプ別、2018～2030年

• 世界のマルチプレックスアッセイ市場：タイプ変動分析
• タンパク質マルチプレックスアッセイ
  • タンパク質マルチプレックスアッセイ市場推定・予測、2018～2030年
• 核酸マルチプレックスアッセイ
  • 核酸マルチプレックスアッセイ市場推定・予測、2018～2030年
• 細胞ベースマルチプレックスアッセイ
  • 細胞ベースマルチプレックスアッセイ市場推定・予測、2018～2030年

第6章 マルチプレックスアッセイ市場：技術別セグメント分析、2018～2030年

• マルチプレックスアッセイ市場：技術変動分析
• フローサイトメトリー
  • フローサイトメトリー市場推定・予測、2018～2030年
• 蛍光検出
  • 蛍光検出市場推定・予測、2018～2030年
• 発光
  • 発光市場推定・予測、2018～2030年
• マルチプレックスリアルタイムPCR
  • マルチプレックスリアルタイムPCR市場推定・予測、2018～2030年
• その他
  • その他の技術市場推定・予測、2018～2030年

第7章 マルチプレックスアッセイ市場：セグメント分析、用途別、2018～2030年

• マルチプレックスアッセイ市場：用途変動分析
• 研究開発
• 臨床診断

第8章 マルチプレックスアッセイ市場：セグメント分析、最終用途別、2018～2030年

• マルチプレックスアッセイ市場：最終用途変動分析
• 製薬・バイオテクノロジー企業
• 病院と診断ラボ
• 研究・学術機関
• その他

第9章 マルチプレックスアッセイ市場：地域別セグメント分析、2018～2030年

• マルチプレックスアッセイ市場：地域変動分析
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 参入企業概要
• 企業/競合の分類
• ベンダー情勢
  • BIO-RAD LABORATORIES, INC.
  • ABCAM PLC.
  • R&D SYSTEMS, INC.
  • MERCK KGAA
  • ASSAY GENIE
  • PROMEGA CONNECTIONS
  • QIAGEN NV
  • THERMO FISHER SCIENTIFIC, INC.
  • LUMINEX CORPORATION
  • PERKIN ELMER INC.
  • ADVANCED CELL DIAGNOSTICS, INC.
  • SEEGENE INC.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 5 Global Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 6 Global Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 7 Global Multiplex Assay Market, by End User, 2018 - 2030 (USD Million)
• Table 8 Global Multiplex Assay Market, by Region, 2018 - 2030 (USD Million)
• Table 9 North America Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 10 North America Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 11 North America Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 12 North America Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 13 North America Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 14 North America Multiplex Assay Market, by End User, 2018 - 2030 (USD Million)
• Table 15 U.S. Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 16 U.S. Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 17 U.S. Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 18 U.S. Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 19 U.S. Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 20 Canada Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Canada Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 22 Canada Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 23 Canada Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 24 Canada Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 25 Mexico Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 26 Mexico Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 27 Mexico Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 28 Mexico Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 29 Mexico Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 30 Europe Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 31 Europe Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Europe Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 33 Europe Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 34 Europe Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 35 Europe Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 36 Germany Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 37 Germany Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 38 Germany Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 39 Germany Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 40 Germany Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 41 UK Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 42 UK Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 43 UK Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 44 UK Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 45 UK Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 46 France Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 47 France Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 48 France Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 49 France Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 50 France Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 51 Italy Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Italy Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 53 Italy Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 54 Italy Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 55 Italy Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 56 Spain Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 57 Spain Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 58 Spain Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 59 Spain Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 60 Spain Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 61 Denmark Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 62 Denmark Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 63 Denmark Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 64 Denmark Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 65 Denmark Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 66 Sweden Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 67 Sweden Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 68 Sweden Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 69 Sweden Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 70 Sweden Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 71 Norway Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Norway Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 73 Norway Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 74 Norway Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 75 Norway Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 82 China Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 83 China Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 84 China Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 85 China Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 86 China Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 87 Japan Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 88 Japan Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 89 Japan Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 90 Japan Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 91 Japan Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 92 India Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 93 India Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 94 India Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 95 India Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 96 India Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 97 South Korea Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 98 South Korea Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 99 South Korea Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 100 South Korea Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 101 South Korea Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 102 Australia Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 103 Australia Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 104 Australia Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 105 Australia Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 106 Australia Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 107 Thailand Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 108 Thailand Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 109 Thailand Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 110 Thailand Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 111 Thailand Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 112 Latin America Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 113 Latin America Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 114 Latin America Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 115 Latin America Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 116 Latin America Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 117 Latin America Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 118 Brazil Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 119 Brazil Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 120 Brazil Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 121 Brazil Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 122 Brazil Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 123 Argentina Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 124 Argentina Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 125 Argentina Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 126 Argentina Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 127 Argentina Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa Multiplex Assay Market, by Country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 134 South Africa Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 135 South Africa Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 136 South Africa Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 137 South Africa Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 138 South Africa Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 144 UAE Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 145 UAE Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 146 UAE Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 147 UAE Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 148 UAE Multiplex Assay Market, End User, 2018 - 2030 (USD Million)
• Table 149 Kuwait Multiplex Assay Market, by Product, 2018 - 2030 (USD Million)
• Table 150 Kuwait Multiplex Assay Market, by Type, 2018 - 2030 (USD Million)
• Table 151 Kuwait Multiplex Assay Market, by Technology, 2018 - 2030 (USD Million)
• Table 152 Kuwait Multiplex Assay Market, by Application, 2018 - 2030 (USD Million)
• Table 153 Kuwait Multiplex Assay Market, End User, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Multiplex Assays Market Segmentation
• Fig. 8 Market Snapshot, 2021
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
• Fig. 16 Global Multiplex Assay Market: Products Movement Analysis
• Fig. 17 Global Multiplex Assay Market, for Consumables, 2018 - 2030 (USD Million)
• Fig. 18 Global Multiplex Assay Market, for Instruments, 2018 - 2030 (USD Million)
• Fig. 19 Global Multiplex Assay Market, for Software, 2018 - 2030 (USD Million)
• Fig. 20 Global Multiplex Assay Market: Type Movement Analysis
• Fig. 21 Global Multiplex Assay Market, for Protein Multiplex Assays, 2018 - 2030 (USD Million)
• Fig. 22 Global Multiplex Assay Market, for Planar Protein Assays, 2018 - 2030 (USD Million)
• Fig. 23 Global Multiplex Assay Market, for Bead-Based Protein Assays, 2018 - 2030 (USD Million)
• Fig. 24 Global Multiplex Assay Market, for Nucleic Acid Multiplex Assays, 2018 - 2030 (USD Million)
• Fig. 25 Global Multiplex Assay Market, for Planar Nucleic Acid Assays, 2018 - 2030 (USD Million)
• Fig. 26 Global Multiplex Assay Market, for Bead-Based Nucleic Acid Assays, 2018 - 2030 (USD Million)
• Fig. 27 Global Multiplex Assay Market, for Cell-Based Multiplex Assays, 2018 - 2030 (USD Million)
• Fig. 28 Global Multiplex Assay Market: Technology Movement Analysis
• Fig. 29 Global Multiplex Assay Market, for Flow Cytometry, 2018 - 2030 (USD Million)
• Fig. 30 Global Multiplex Assay Market, for Fluorescence Detection, 2018 - 2030 (USD Million)
• Fig. 31 Global Multiplex Assay Market, for Luminescence,2018 - 2030 (USD Million)
• Fig. 32 Global Multiplex Assay Market, for Multiplex Real-Time PCR, 2018 - 2030 (USD Million)
• Fig. 33 Global Multiplex Assay Market, for Other Technologies, 2018 - 2030 (USD Million)
• Fig. 34 Global Multiplex Assay Market: Application Movement Analysis
• Fig. 35 Global Multiplex Assay Market, for Research & Development, 2018 - 2030 (USD Million)
• Fig. 36 Global Multiplex Assay Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
• Fig. 37 Global Multiplex Assay Market, for Biomarker Discovery & Validation, 2018 - 2030 (USD Million)
• Fig. 38 Global Multiplex Assay Market, for Clinical Diagnostics, 2018 - 2030 (USD Million)
• Fig. 39 Global Multiplex Assay Market, for Infectious Diseases, 2018 - 2030 (USD Million)
• Fig. 40 Global Multiplex Assay Market, for Cancer, 2018 - 2030 (USD Million)
• Fig. 41 Global Multiplex Assay Market, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
• Fig. 42 Global Multiplex Assay Market, for Autoimmune Diseases, 2018 - 2030 (USD Million)
• Fig. 43 Global Multiplex Assay Market, for Nervous System Disorders, 2018 - 2030 (USD Million)
• Fig. 44 Global Multiplex Assay Market, for Metabolism & Endocrinology Disorders, 2018 - 2030 (USD Million)
• Fig. 45 Global Multiplex Assay Market, for Other Diseases, 2018 - 2030 (USD Million)
• Fig. 46 Global Multiplex Assay Market: End User Movement Analysis
• Fig. 47 Global Multiplex Assay Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 48 Global Multiplex Assay Market, for Hospitals & Diagnostic Laboratories, 2018 - 2030 (USD Million)
• Fig. 49 Global Multiplex Assay Market, for Research & Academic Institutes, 2018 - 2030 (USD Million)
• Fig. 50 Global Multiplex Assay Market, for Other End Users, 2018 - 2030 (USD Million)
• Fig. 51 Regional Marketplace: Key Takeaways
• Fig. 52 Regional Outlook, 2024 & 2030
• Fig. 53 Global Multiplex Assay Market: Regional Movement Analysis
• Fig. 54 North America Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 55 U.S. Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 56 Canada Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 57 Mexico Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 58 Europe Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 59 Germany Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 60 UK Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 61 France Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 62 Italy Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 63 Spain Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 64 Denmark Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 65 Sweden Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 66 Norway Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 67 Asia Pacific Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 68 Japan Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 69 China Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 70 India Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 71 South Korea Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 72 Australia Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 73 Thailand Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 74 Latin America Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 75 Brazil Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 76 Argentina Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 77 Middle East and Africa Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 78 South Africa Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 79 Saudi Arabia Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 80 UAE Multiplex Assay Market, 2018 - 2030 (USD Million)
• Fig. 81 Kuwait Multiplex Assay Market, 2018 - 2030 (USD Million)

Multiplex Assay Market Growth & Trends:

The global multiplex assay market size is estimated to reach USD 4,412.72 million by 2030, registering to grow at a CAGR of 17.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growing prevalence of infectious diseases is boosting the usage of multiplex assays in clinical trials. For instance, according to the American Cancer Society in 2021, 1.9 million cancer cases were reported along with 6,08,570 deaths in the United States. Multiplex assay aids in the diagnosis of cancer and reduces unnecessary invasive producers. Thus, growing chronic diseases can boost the necessity of these assays and is anticipated to fuel market growth. The increasing adoption of personalized medicine in recent years is another key factor driving the growth.

Personalized medicine is a precise medicine for an individual patient to attain improved treatment options based on the body type and disease risk. These assays ensure to be highly beneficial for the comprehensive diagnosis of personalized medicines. For instance, according to an article published in the MDPI journal in 2020, multiplex immunoassay provides a complete picture of the disease and pathways involved in Rheumatoid Arthritis (RA) and simultaneously analyzes multiple proteins that can yield biomarker signatures of RA subtypes to enable patients to benefit from personalized medicine. During the COVID-19 pandemic, multiplex testing continued to be an essential tool for healthcare professionals in effectively managing the spread of COVID-19. In addition, recently, several private companies have also developed novel versions of multiplex assays.

For instance, in Sept 2020, LabCorp launched an at-home collection version for diagnosis of influenza A/B, COVID-19, and respiratory syncytial virus single-panel tests. Furthermore, the advantages of multiplex assay over singleplex and traditional assay can boost the industry growth in coming years. Several benefits offered by these automated tests include microsampling capability, numerous arrays measured in a single trial, quicker results, high operational efficiency, easy operations, and reduced labor expenses. Thus, the industry has witnessed incremental growth in 2021 and is anticipated to have a similar trend during the forecast period. Moreover, increasing validation of the biomarkers in molecular & protein diagnostics and the rising need for high-throughput and automated systems are expected to create lucrative opportunities during the forecast period.

Multiple biomarker analysis has a wide range of applications in the area of infectious diseases, neurodegenerative diseases, autoimmune diseases, and cancer. Numerous biomarkers are being discovered, and there is a high possibility of the development of novel diagnostics. For instance, Cipla launched RT Direct multiplex PCR kit that delivers quicker results for COVID-19. Such developments can increase the market penetration of multiplex assay during the forecast period. The technological advancements and automation in the multiplex assay, improve the efficiency and speed of delivering accurate results. For instance, in July 2020, Luminex provided xMAP the INTELLIFLEX system to discover novel applications, including the exclusive ability to detect multiple antibodies in a single serology test.

In May 2022, Vela Diagnostics launched a highly automated multiplex PCR-based test for detecting antimicrobial resistance genes and UTI pathogens. Hence novel technological developments can fuel the industry growth in the near future. However, the high cost of equipment can restrict the usage of multiplex assays by researchers and manufacturers in mid and low-income countries. Also, the quality control standards and regulations are more stringent for multiplex assay compared to singlex assay, which can impede the industry growth during the forecast period.

Multiplex Assay Market Report Highlights:

• By product, the consumables segment held the dominant share in 2024. This is due to the recurring purchase of consumables along with the rise in the number of diagnostic tests.
• The protein multiplex assay type segment dominated the industry in 2024 due to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.
• The flow cytometry technology segment held a larger share in 2024. Constant efforts by various companies to launch novel and technological advanced flow cytometer is the key factor driving the segment.
• The research & development application segment held the largest share in 2024 due to the utilization of these assays in clinical & preclinical stages to evaluate toxicity, immunotherapy success, and drug response biomarkers.
• The pharmaceutical & biotechnology companies end-user segment led the industry in 2024 due to a rise in pharma & biotech partnerships and collaborations to increase the multiplexing capabilities.
• North America dominated the global industry in 2024 due to the growing R&D activities as a result of the increasing prevalence of chronic diseases.
• Asia Pacific is estimated to register the fastest CAGR from 2024 to 2030 due to the rising number of hospitals in emerging countries, the developing R&D sector, and the high demand for healthcare infrastructure in the region.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity flow approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
• 1.12 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Summary
• 2.2 Market Snapshot
• 2.3 Segment Snapshot
• 2.3 Competitive Snapshot

Chapter 3 Global Multiplex Assay Market Variables, Trends, & Scope

• 3.1 Multiplex Assay Market Lineage Outlook
  • 3.1.1 Parent market outlook
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Market Driver Analysis
  • 3.3.1 Growing prevalence of chronic and infectious diseases
  • 3.3.2 Significant advantages of multiplex over singleplex and traditional assays
  • 3.3.3 Increasing applications of multiplex assays in companion diagnostics
  • 3.3.4 Rising awareness of early diagnosis
• 3.4 Market Restraint Analysis
  • 3.4.1 The high investment cost of multiplex assays
  • 3.4.2 Stringent regulatory constraints and standards
• 3.5 Market Opportunity Analysis
  • 3.5.1 Growing need for high-throughput and automated systems
  • 3.5.2 Increasing validation of the biomarkers in protein and molecular diagnostics
• 3.6 Porter's Five Forces Analysis
• 3.7 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)

Chapter 4 Multiplex Assay Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 4.1 Global Multiplex Assay Market: Product Movement Analysis
• 4.2 Consumables
  • 4.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
• 4.3 Instruments
  • 4.3.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• 4.4 Software
  • 4.4.1 Software market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Multiplex Assay Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

• 5.1 Global Multiplex Assay Market: Type Movement Analysis
• 5.2 Protein Multiplex Assays
  • 5.2.1 Protein multiplex assays market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.2.1.1 Planar Protein Assays
      • 5.2.1.1.1 Planar Protein Assays Market, 2018 - 2030 (USD Million)
    • 5.2.1.2 Bead-Based Protein Assays
      • 5.2.1.2.1 Bead-Based Protein Assays Market, 2018 - 2030 (USD Million)
• 5.3 Nucleic Acid Multiplex Assays
  • 5.3.1 Nucleic Acid Multiplex Assays market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.1.1 Planar Nucleic Acid Assays
      • 5.3.1.1.1 Planar Nucleic Acid Assays Market, 2018 - 2030 (USD Million)
    • 5.3.1.2 Bead-Based Nucleic Acid Assays
      • 5.3.1.2.1 Bead-Based Nucleic Acid Assays Market, 2018 - 2030 (USD Million)
• 5.4 Cell-Based Multiplex Assays
  • 5.4.1 Cell-Based Multiplex Assays market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Multiplex Assay Market- Segment Analysis, by Technology, 2018 - 2030 (USD Million)

• 6.1 Multiplex Assay Market: Technology Movement Analysis
• 6.2 Flow Cytometry
  • 6.2.1 Flow Cytometry market estimates and forecast, 2018 - 2030 (USD Million)
• 6.3 Fluorescence Detection
  • 6.3.1 Fluorescence Detection market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4 Luminescence
  • 6.4.1 Luminescence market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5 Multiplex Real-Time PCR
  • 6.5.1 Multiplex Real-Time PCR market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6 Other Technologies
  • 6.6.1 Other Technologies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Multiplex Assay Market: - Segment Analysis, by Application, 2018 - 2030 (USD Million)

• 7.1 Multiplex Assay Market: Application Movement Analysis
• 7.2 Research & Development
  • 7.2.1 Research & Development market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.2.1.1 Drug Discovery & Development
      • 7.2.1.1.1 Drug Discovery & Development Market, 2018 - 2030 (USD Million)
    • 7.2.1.2 Biomarker Discovery & Validation
      • 7.2.1.2.1 Biomarker Discovery & Validation Market, 2018 - 2030 (USD Million)
• 7.3 Clinical Diagnostics
  • 7.3.1 Clinical Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.1.1 Infectious Diseases
      • 7.3.1.1.1 Infectious Diseases Market, 2018 - 2030 (USD Million)
    • 7.3.1.2 Cancer
      • 7.3.1.2.1 Cancer Market, 2018 - 2030 (USD Million)
    • 7.3.1.3 Cardiovascular Diseases
      • 7.3.1.3.1 Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
    • 7.3.1.4 Autoimmune Diseases
      • 7.3.1.4.1 Autoimmune Diseases Market, 2018 - 2030 (USD Million)
    • 7.3.1.5 Nervous System Disorders
      • 7.3.1.5.1 Nervous System Disorders Market, 2018 - 2030 (USD Million)
    • 7.3.1.6 Metabolism & Endocrinology Disorders
      • 7.3.1.6.1 Metabolism & Endocrinology Disorders Market, 2018 - 2030 (USD Million)
    • 7.3.1.7 Other Diseases
      • 7.3.1.7.1 Other Diseases Market, 2018 - 2030 (USD Million)

Chapter 8 Multiplex Assay Market: - Segment Analysis, by End User, 2018 - 2030 (USD Million)

• 8.1 Multiplex Assay Market: End User Movement Analysis
• 8.2 Pharmaceutical & Biotechnology Companies
  • 8.2.1 Pharmaceutical & Biotechnology Companies market estimates and forecast, 2018 - 2030 (USD Million)
• 8.3 Hospitals & Diagnostic laboratories
  • 8.3.1 Hospitals & Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
• 8.4 Research & Academic Institutes
  • 8.4.1 Research & Academic Institutes market estimates and forecast, 2018 - 2030 (USD Million)
• 8.5 Other End Users
  • 8.5.1 Other End Users market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Multiplex Assay Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 9.1 Multiplex Assay Market: Regional Movement Analysis
• 9.2 North America
  • 9.2.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.2.2 U.S.
    • 9.2.2.1 Key Country Dynamics
    • 9.2.2.2 Competitive Scenario
    • 9.2.2.3 Prevalence Insights
    • 9.2.2.4 Regulatory Framework
    • 9.2.2.5 Reimbursement Structure
    • 9.2.2.6 U.S. Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.2.3 Canada
    • 9.2.3.1 Key Country Dynamics
    • 9.2.3.2 Competitive Scenario
    • 9.2.3.3 Prevalence Insights
    • 9.2.3.4 Regulatory Framework
    • 9.2.3.5 Reimbursement Structure
    • 9.2.3.6 Canada Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3 Mexico
    • 9.3.3.1 Key Country Dynamics
    • 9.3.3.2 Competitive Scenario
    • 9.3.3.3 Prevalence Insights
    • 9.3.3.4 Regulatory Framework
    • 9.3.3.5 Reimbursement Structure
    • 9.3.3.6 Mexico Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.3 Europe
  • 9.3.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3.2 UK
    • 9.3.2.1 Key Country Dynamics
    • 9.3.2.2 Competitive Scenario
    • 9.3.2.3 Prevalence Insights
    • 9.3.2.4 Regulatory Framework
    • 9.3.2.5 Reimbursement Structure
    • 9.3.2.6 UK Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.3. Germany
    • 9.3.3.1 Key Country Dynamics
    • 9.3.3.2 Competitive Scenario
    • 9.3.3.3 Prevalence Insights
    • 9.3.3.4 Regulatory Framework
    • 9.3.3.5 Reimbursement Structure
    • 9.3.3.6 Germany Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.4 Spain
    • 9.3.4.1 Key Country Dynamics
    • 9.3.4.2 Competitive Scenario
    • 9.3.4.3 Prevalence Insights
    • 9.3.4.4 Regulatory Framework
    • 9.3.4.5 Reimbursement Structure
    • 9.3.4.6 Spain Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.5 France
    • 9.3.5.1 Key Country Dynamics
    • 9.3.5.2 Competitive Scenario
    • 9.3.5.3 Prevalence Insights
    • 9.3.5.4 Regulatory Framework
    • 9.3.5.5 Reimbursement Structure
    • 9.3.5.6 France Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.6 Italy
    • 9.3.6.1 Key Country Dynamics
    • 9.3.6.2 Competitive Scenario
    • 9.3.6.3 Prevalence Insights
    • 9.3.6.4 Regulatory Framework
    • 9.3.6.5 Reimbursement Structure
    • 9.3.6.6 Italy Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.7 Denmark
    • 9.3.7.1 Key Country Dynamics
    • 9.3.7.2 Competitive Scenario
    • 9.3.7.3 Prevalence Insights
    • 9.3.7.4 Regulatory Framework
    • 9.3.7.5 Reimbursement Structure
    • 9.3.7.6 Denmark Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.8 Sweden
    • 9.3.8.1 Key Country Dynamics
    • 9.3.8.2 Competitive Scenario
    • 9.3.8.3 Prevalence Insights
    • 9.3.8.4 Regulatory Framework
    • 9.3.8.5 Reimbursement Structure
    • 9.3.8.6 Sweden Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3.9 Norway
    • 9.3.9.1 Key Country Dynamics
    • 9.3.9.2 Competitive Scenario
    • 9.3.9.3 Prevalence Insights
    • 9.3.9.4 Regulatory Framework
    • 9.3.9.5 Reimbursement Structure
    • 9.3.9.6 Norway Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.4 Asia Pacific
  • 9.4.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.2 Japan
    • 9.4.2.1 Key Country Dynamics
    • 9.4.2.2 Competitive Scenario
    • 9.4.2.3 Prevalence Insights
    • 9.4.2.4 Regulatory Framework
    • 9.4.2.5 Reimbursement Structure
    • 9.4.2.6 Japan Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3 China
    • 9.4.3.1 Key Country Dynamics
    • 9.4.3.2 Competitive Scenario
    • 9.4.3.3 Prevalence Insights
    • 9.4.3.4 Regulatory Framework
    • 9.4.3.5 Reimbursement Structure
    • 9.4.3.6 China Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4 India
    • 9.4.4.1 Key Country Dynamics
    • 9.4.4.2 Competitive Scenario
    • 9.4.4.3 Prevalence Insights
    • 9.4.4.4 Regulatory Framework
    • 9.4.4.5 Reimbursement Structure
    • 9.4.4.6 India Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.5 South Korea
    • 9.4.5.1 Key Country Dynamics
    • 9.4.5.2 Competitive Scenario
    • 9.4.5.3 Prevalence Insights
    • 9.4.5.4 Regulatory Framework
    • 9.4.5.5 Reimbursement Structure
    • 9.4.5.6 South Korea Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.6 Australia
    • 9.4.6.1 Key Country Dynamics
    • 9.4.6.2 Competitive Scenario
    • 9.4.6.3 Prevalence Insights
    • 9.4.6.4 Regulatory Framework
    • 9.4.6.5 Reimbursement Structure
    • 9.4.6.6 Australia Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.7 Thailand
    • 9.4.7.1 Key Country Dynamics
    • 9.4.7.2 Competitive Scenario
    • 9.4.7.3 Prevalence Insights
    • 9.4.7.4 Regulatory Framework
    • 9.4.7.5 Reimbursement Structure
    • 9.4.7.6 Thailand Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5 Latin America
  • 9.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.2 Brazil
    • 9.5.2.1 Key Country Dynamics
    • 9.5.2.2 Competitive Scenario
    • 9.5.2.3 Prevalence Insights
    • 9.5.2.4 Regulatory Framework
    • 9.5.2.5 Reimbursement Structure
    • 9.5.2.6 Brazil Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3 Argentina
    • 9.5.3.1 Key Country Dynamics
    • 9.5.3.2 Competitive Scenario
    • 9.5.3.3 Prevalence Insights
    • 9.5.3.4 Regulatory Framework
    • 9.5.3.5 Reimbursement Structure
    • 9.5.3.6 Argentina Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6 Middle East & Africa (MEA)
  • 9.6.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6.2 South Africa
    • 9.6.2.1 Key Country Dynamics
    • 9.6.2.2 Competitive Scenario
    • 9.6.2.3 Prevalence Insights
    • 9.6.2.4 Regulatory Framework
    • 9.6.2.5 Reimbursement Structure
    • 9.6.2.6 South Africa Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3 Saudi Arabia
    • 9.6.3.1 Key Country Dynamics
    • 9.6.3.2 Competitive Scenario
    • 9.6.3.3 Prevalence Insights
    • 9.6.3.4 Regulatory Framework
    • 9.6.3.5 Reimbursement Structure
    • 9.6.3.6 Saudi Arabia Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4 UAE
    • 9.6.4.1 Key Country Dynamics
    • 9.6.4.2 Competitive Scenario
    • 9.6.4.3 Prevalence Insights
    • 9.6.4.4 Regulatory Framework
    • 9.6.4.5 Reimbursement Structure
    • 9.6.4.6 UAE Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5 Kuwait
    • 9.6.5.1 Key Country Dynamics
    • 9.6.5.2 Competitive Scenario
    • 9.6.5.3 Prevalence Insights
    • 9.6.5.4 Regulatory Framework
    • 9.6.5.5 Reimbursement Structure
    • 9.6.5.6 Kuwait Multiplex Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Landscape

• 10.1 Participant's overview
• 10.2 Company/Competition Categorization
• 10.3 Vendor Landscape
  • 10.3.1 BIO-RAD LABORATORIES, INC.
    • 10.3.1.1 Company overview
    • 10.3.1.2 Financial performance
    • 10.3.1.3 Services benchmarking
    • 10.3.1.4 Strategic initiatives
  • 10.3.2 ABCAM PLC.
    • 10.3.2.1 Company overview
    • 10.3.2.2 Financial performance
    • 10.3.2.3 Services benchmarking
    • 10.3.2.4 Strategic initiatives
  • 10.3.3 R&D SYSTEMS, INC.
    • 10.3.3.1 Company overview
    • 10.3.3.2 Financial performance
    • 10.3.3.3 Services benchmarking
    • 10.3.3.4 Strategic initiatives
  • 10.3.4 MERCK KGAA
    • 10.3.4.1 Company overview
    • 10.3.4.2 Financial performance
    • 10.3.4.3 Services benchmarking
    • 10.3.4.4 Strategic initiatives
  • 10.3.5 ASSAY GENIE.
    • 10.3.5.1 Company overview
    • 10.3.5.2 Financial performance
    • 10.3.5.3 Services benchmarking
    • 10.3.5.4 Strategic initiatives
  • 10.3.6 PROMEGA CONNECTIONS
    • 10.3.6.1 Company overview
    • 10.3.6.2 Financial performance
    • 10.3.6.3 Services benchmarking
    • 10.3.6.4 Strategic initiatives
  • 10.3.7 QIAGEN N.V.
    • 10.3.7.1 Company overview
    • 10.3.7.2 Financial performance
    • 10.3.7.3 Services benchmarking
    • 10.3.7.4 Strategic initiatives
  • 10.3.8 THERMO FISHER SCIENTIFIC, INC.
    • 10.3.8.1 Company overview
    • 10.3.8.2 Financial performance
    • 10.3.8.3 Services benchmarking
    • 10.3.8.4 Strategic initiatives
  • 10.3.9 LUMINEX CORPORATION
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Services benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10 PERKIN ELMER INC.
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Services benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11 ADVANCED CELL DIAGNOSTICS, INC.
    • 10.3.11.1 Company overview
    • 10.3.11.2 Financial performance
    • 10.3.11.3 Services benchmarking
    • 10.3.11.4 Strategic initiatives
  • 10.1.12 SEEGENE INC.
    • 10.3.12.1 Company overview
    • 10.3.12.2 Financial performance
    • 10.3.12.3 Services benchmarking
    • 10.3.12.4 Strategic initiatives